Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering

Summary by WBOC 16
Silence Therapeutics plc (“Silence” or the “Company”) , a global clinical-stage biotechnology company developing novel

3 Articles

WBOC 16WBOC 16
Center

Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering

Silence Therapeutics plc (“Silence” or the “Company”) , a global clinical-stage biotechnology company developing novel

Read Full Article
Business WireBusiness Wire

Silence Therapeutics Reports Second Quarter 2026 Financial and Business Results

·Crystal River, United States
Read Full Article
stocktitan.netstocktitan.net

DiaMedica Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news on Monday, August 10, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal